CRYSTALGENOMICS INC. |
End-of-day quote
Other stock markets
|
||
| - | - |
|
| Sales 2022 | 38.64B 28.09M 0 2.25B | Sales 2023 | 4.88B 3.55M 0 284M | Capitalization | 208B 151M 0 12.12B |
|---|---|---|---|---|---|
| Net income 2022 | -23.87B -17.35M - -1.39B | Net income 2023 | -48.92B -35.57M - -2.85B | EV / Sales 2022 | 5.93 x |
| Net cash position 2022 | 11.83B 8.6M 0 689M | Net cash position 2023 | 12.29B 8.93M 0 715M | EV / Sales 2023 | 40.2 x |
| P/E ratio 2022 |
-10.1
x | P/E ratio 2023 |
-4.2
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 77.42% |
More Fundamentals
* Assessed data
More news
| Managers | Title | Age | Since |
|---|---|---|---|
Joong-Myung Cho
CEO | Chief Executive Officer | 75 | 31/12/99 |
Young-Joon Yoo
AUD | Comptroller/Controller/Auditor | 52 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Joong-Myung Cho
CEO | Chief Executive Officer | 75 | 31/12/99 |
Jin-Woo Lee
BRD | Director/Board Member | 59 | 30/03/17 |
Kyung-Sook Cho
BRD | Director/Board Member | 64 | - |
CG Invites Co Ltd is a Korea-based company principally engaged in the development and manufacturing of pharmaceuticals. The Company operates its business through three segments. The Pharmaceutical Research and Development segment is engaged in the research, development and sale of new drugs such as anti-inflammatory painkillers, anticancer drugs, anti-infectives and others. It is also engaged in the real estate rental business. The Pharmaceutical Manufacturing segment is engaged in the manufacture, retail and wholesale of finished drug products. The Other segment is engaged in the manufacture and sale of hot packs and other household items.
Sector
Pharmaceuticals
Calendar
12/05/2024
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
